We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Regeneron’s COVID-19 Antibody Therapy Cuts Viral Load, Medical Visits
Regeneron’s COVID-19 Antibody Therapy Cuts Viral Load, Medical Visits
Data from Regeneron’s phase 2/3 trial of its COVID-19 antibody cocktail showed the treatment significantly reduced viral load and the number of medical visits needed by nonhospitalized patients, the company said Thursday.